← Back to Clinical Trials
Recruiting NCT06358339

NCT06358339 TEEM-GIFTS: A Gamified mHealth to Reduce Post-Discharge Suicide Risk

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06358339
Status Recruiting
Phase
Sponsor Shenzhen Kangning Hospital
Condition Suicide
Study Type INTERVENTIONAL
Enrollment 640 participants
Start Date 2025-05-01
Primary Completion 2027-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
TEEM

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 640 participants in total. It began in 2025-05-01 with a primary completion date of 2027-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients with mental disorders are at significantly higher risk of suicide after discharge compared to the general population and patients with other diseases. Currently, there is a lack of post-discharge community suicide risk management services in China. The research team's preliminary research suggests that mHealth interventions are well-accepted and feasible for reducing the suicide risk in patients with mental disorders. Furthermore, the inclusion of gamification elements can enhance treatment adherence and user engagement. However, determining the appropriate combination of gamification elements and evaluating the implementation effectiveness of gamified mHealth interventions for suicide risk are challenges in transforming these into regular community mental health services. This study will leverage gamification theory and community-based participatory research to design a gamified mHealth intervention model aimed at reducing suicide risk among discharged patients with mental disorders, and to develop a corresponding management strategy. Using the multi-phase optimization strategy (MOST), the study will identify the optimal combination of gamification elements to reduce suicide risk and increase the outpatient follow-up rate. Through an implementation science framework, the investigators will evaluate the process, outcomes, cost, and feasibility of this management strategy with the goal of reducing suicide risk among these patients. The findings from this study will provide a scientific basis for innovative suicide risk management models for discharged patients with mental disorders in China, thereby paving the way for the application of implementation science in mental health.

Eligibility Criteria

Inclusion Criteria: For patients * Being 18 years and above; * Being diagnosed with mental disorders; * Having received inpatient care for three days or more; * Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge; * Being able to use apps or WeChat (WeChat mini program) on smart phones. For lay health care supporters (LHSs) * Being 18 years and above; * Being without any diagnosis of mental disorder; * Being the lay health care supporter in the family; * Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge; * Being able to use apps or WeChat (WeChat mini program) on smart phones. For the clinic and community mental health service providers * Being 18 years and above; * Having practiced in mental health service at least for 12 months. Exclusion criteria For patients * Refusing to provide written consent or be unable to provide written consent due to any cognitive problems. * Being discharged by the patient's or LHSs' demand against medical advice. * With no ID, no stable residence nor any source of income. For For lay health care supporters (LHSs) * Refusing to provide written consent. For the clinic and community mental health service providers * Refusing to provide written consent.

Contact & Investigator

Central Contact

Fengsu Hou, Ph.D.

✉ houfengsu@gmail.com

📞 +86-18502864780

Principal Investigator

Fengsu Hou, Ph.D.

PRINCIPAL INVESTIGATOR

Shenzhen Kangning Hospital

Frequently Asked Questions

Who can join the NCT06358339 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06358339 currently recruiting?

Yes, NCT06358339 is actively recruiting participants. Contact the research team at houfengsu@gmail.com for enrollment information.

Where is the NCT06358339 trial being conducted?

This trial is being conducted at Shenzhen, China.

Who is sponsoring the NCT06358339 clinical trial?

NCT06358339 is sponsored by Shenzhen Kangning Hospital. The principal investigator is Fengsu Hou, Ph.D. at Shenzhen Kangning Hospital. The trial plans to enroll 640 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology